"POLB is framed as a micro-cap with a large AI-driven oral GLP-1 weight-loss program and additional cancer-treatment AI initiatives, where the speaker expects a large revenue/profit ramp that could justify dramatic upside from today’s scale."
"These 2 Stocks Will Make Me A Billionaire by 2028! NASDAQ: RXRX, LON: POLB!"